Melatonin Alleviates Age-Associated Endothelial Injury of Atherosclerosis via Regulating Telomere Function

References

• Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852–1866. doi:10.1161/CIRCRESAHA.114.302721
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen KJ. Atherosclerosis, vascular aging and therapeutic strategies. Chin J Integr Med. 2012;18(2):83–87. doi:10.1007/s11655-012-0996-z
   PubMed Web of Science ®Google Scholar
• Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33(13):1635–1701. doi:10.1093/eurheartj/ehs092
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492. doi:10.1161/CIR.0000000000000558
   PubMed Web of Science ®Google Scholar
• Sturlaugsdottir R, Aspelund T, Bjornsdottir G, et al. Prevalence and determinants of carotid plaque in the cross-sectional REFINE-Reykjavik study. BMJ Open. 2016;6(11):e012457. doi:10.1136/bmjopen-2016-012457
   PubMed Web of Science ®Google Scholar
• Shay JW, Wright WE. Telomeres and telomerase: three decades of progress. Nat Rev Genet. 2019;20(5):299–309. doi:10.1038/s41576-019-0099-1
   PubMed Web of Science ®Google Scholar
• Minamino T, Komuro I. Role of telomere in endothelial dysfunction in atherosclerosis. Curr Opin Lipidol. 2002;13(5):537–543. doi:10.1097/00041433-200210000-00010
   PubMed Web of Science ®Google Scholar
• Minamino T, Miyauchi H, Yoshida T, Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomeres in endothelial dysfunction. J Cardiol. 2003;41(1):39–40.
   PubMedGoogle Scholar
• Doshida M, Ohmichi M, Tsutsumi S, et al. Raloxifene increases proliferation and up-regulates telomerase activity in human umbilical vein endothelial cells. J Biol Chem. 2006;281(34):24270–24278. doi:10.1074/jbc.M513251200
   PubMed Web of Science ®Google Scholar
• Bennaceur K, Atwill M, Al Zhrany N, et al. Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism. Atherosclerosis. 2014;236(2):312–320. doi:10.1016/j.atherosclerosis.2014.07.020
   PubMed Web of Science ®Google Scholar
• Pu DR, Liu L. HDL slowing down endothelial progenitor cells senescence: a novel anti-atherogenic property of HDL. Med Hypotheses. 2008;70(2):338–342. doi:10.1016/j.mehy.2007.05.025
   PubMed Web of Science ®Google Scholar
• Anderson G, Vaillancourt C, Maes M, Reiter RJ. Breastfeeding and the gut-brain axis: is there a role for melatonin? Biomol Concepts. 2017;8(3–4):185–195. doi:10.1515/bmc-2017-0009
   PubMedGoogle Scholar
• Yang Y, Sun Y, Yi W, et al. A review of melatonin as a suitable antioxidant against myocardial ischemia-reperfusion injury and clinical heart diseases. J Pineal Res. 2014;57(4):357–366. doi:10.1111/jpi.12175
   PubMed Web of Science ®Google Scholar
• Hu ZP, Fang XL, Fang N, et al. Melatonin ameliorates vascular endothelial dysfunction, inflammation, and atherosclerosis by suppressing the TLR4/NF-kappaB system in high-fat-fed rabbits. J Pineal Res. 2013;55(4):388–398. doi:10.1111/jpi.12085
   PubMed Web of Science ®Google Scholar
• Hung MW, Kravtsov GM, Lau CF, Poon AM, Tipoe GL, Fung ML. Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia. J Pineal Res. 2013;55(3):247–256. doi:10.1111/jpi.12067
   PubMed Web of Science ®Google Scholar
• Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. The potential usefulness of serum melatonin level to predict heart failure in patients with hypertensive cardiomyopathy. Int J Cardiol. 2014;174(2):415–417. doi:10.1016/j.ijcard.2014.04.044
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Patel KK, Dehari D, Agrawal AK, Singh S. Melatonin and its ubiquitous anticancer effects. Mol Cell Biochem. 2019;462(1–2):133–155. doi:10.1007/s11010-019-03617-5
   PubMed Web of Science ®Google Scholar
• Habtemariam S, Daglia M, Sureda A, Selamoglu Z, Gulhan MF, Nabavi SM. Melatonin and respiratory diseases: a review. Curr Top Med Chem. 2017;17(4):467–488. doi:10.2174/1568026616666160824120338
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang T, Lee TH. Cellular mechanisms of melatonin: insight from neurodegenerative diseases. Biomolecules. 2020;10(8):Aug. doi:10.3390/biom10081158
   Web of Science ®Google Scholar
• Miller KP, Ramos KS. Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons. Drug Metab Rev. 2001;33(1):1–35. doi:10.1081/dmr-100000138
   PubMed Web of Science ®Google Scholar
• Iwano S, Asanuma F, Nukaya M, Saito T, Kamataki T. CYP1A1-mediated mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun. 2005;337(2):708–712. doi:10.1016/j.bbrc.2005.09.109
   PubMed Web of Science ®Google Scholar
• Mohammed K, Shervington A. Can CYP1A1 siRNA be an effective treatment for lung cancer? Cell Mol Biol Lett. 2008;13(2):240–249. doi:10.2478/s11658-007-0050-x
   PubMed Web of Science ®Google Scholar
• Kimura M, Stone RC, Hunt SC, et al. Measurement of telomere length by the Southern blot analysis of terminal restriction fragment lengths. Nat Protoc. 2010;5(9):1596–1607. doi:10.1038/nprot.2010.124
   PubMed Web of Science ®Google Scholar
• Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266(5193):2011–2015. doi:10.1126/science.7605428
   PubMed Web of Science ®Google Scholar
• Zheng Z, Wang M, Cheng C, et al. Ginsenoside Rb1 reduces H2O2induced HUVEC dysfunction by stimulating the sirtuin-1/AMPactivated protein kinase pathway. Mol Med Rep. 2020;22(1):247–256. doi:10.3892/mmr.2020.11096
   PubMed Web of Science ®Google Scholar
• Wang JC, Bennett M. Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circ Res. 2012;111(2):245–259. doi:10.1161/CIRCRESAHA.111.261388
   PubMed Web of Science ®Google Scholar
• Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation. 2002;105(13):1541–1544. doi:10.1161/01.cir.0000013836.85741.17
   PubMed Web of Science ®Google Scholar
• Nazari-Shafti TZ, Cooke JP. Telomerase therapy to reverse cardiovascular senescence. Methodist DeBakey Cardiovasc J. 2015;11(3):172–175. doi:10.14797/mdcj-11-3-172
   PubMedGoogle Scholar
• Hsiao R, Sharma HW, Ramakrishnan S, Keith E, Narayanan R. Telomerase activity in normal human endothelial cells. Anticancer Res. 1997;17(2A):827–832.
   PubMed Web of Science ®Google Scholar
• Yang J, Chang E, Cherry AM, et al. Human endothelial cell life extension by telomerase expression. J Biol Chem. 1999;274(37):26141–26148. doi:10.1074/jbc.274.37.26141
   PubMed Web of Science ®Google Scholar
• Zhang H, Hu N. Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway. Mol Med Rep. 2018;18(2):1345–1352. doi:10.3892/mmr.2018.9119
   PubMed Web of Science ®Google Scholar
• Martinez-Campa CM, Alonso-Gonzalez C, Mediavilla MD, Cos S, Gonzalez A, Sanchez-Barcelo EJ. Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells. Cancer Lett. 2008;268(2):272–277. doi:10.1016/j.canlet.2008.04.001
   PubMed Web of Science ®Google Scholar
• Blasiak J, Reiter RJ, Kaarniranta K. Melatonin in retinal physiology and pathology: the case of age-related macular degeneration. Oxid Med Cell Longev. 2016;2016:6819736. doi:10.1155/2016/6819736
   PubMed Web of Science ®Google Scholar
• Barouki R, Morel Y. Repression of cytochrome P450 1A1 gene expression by oxidative stress: mechanisms and biological implications. Biochem Pharmacol. 2001;61(5):511–516. doi:10.1016/s0006-2952(00)00543-8
   PubMed Web of Science ®Google Scholar
• Huang B, Bao J, Cao YR, Gao HF, Jin Y. Cytochrome P450 1A1 (CYP1A1) catalyzes lipid peroxidation of oleic acid-induced HepG2 cells. Biochemistry (Mosc). 2018;83(5):595–602. doi:10.1134/S0006297918050127
   PubMed Web of Science ®Google Scholar
• Lefevre L, Authier H, Stein S, et al. LRH-1 mediates anti-inflammatory and antifungal phenotype of IL-13-activated macrophages through the PPARgamma ligand synthesis. Nat Commun. 2015;6:6801. doi:10.1038/ncomms7801
   PubMed Web of Science ®Google Scholar
• Kahn-Kirby AH, Amagata A, Maeder CI, et al. Targeting ferroptosis: a novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy. PLoS One. 2019;14(3):e0214250. doi:10.1371/journal.pone.0214250
   PubMed Web of Science ®Google Scholar
• Mahipal SV, Subhashini J, Reddy MC, et al. Effect of 15-lipoxygenase metabolites, 15-(S)-HPETE and 15-(S)-HETE on chronic myelogenous leukemia cell line K-562: reactive oxygen species (ROS) mediate caspase-dependent apoptosis. Biochem Pharmacol. 2007;74(2):202–214. doi:10.1016/j.bcp.2007.04.005
   PubMed Web of Science ®Google Scholar
• Shen T, Ma J, Zhang L, et al. Positive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertension. PLoS One. 2013;8(12):e83132. doi:10.1371/journal.pone.0083132
   PubMed Web of Science ®Google Scholar
• Farhat N, Thorin-Trescases N, Voghel G, et al. Stress-induced senescence predominates in endothelial cells isolated from atherosclerotic chronic smokers. Can J Physiol Pharmacol. 2008;86(11):761–769. doi:10.1139/Y08-082
   PubMed Web of Science ®Google Scholar
• Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell. 2004;14(4):501–513. doi:10.1016/s1097-2765(04)00256-4
   PubMed Web of Science ®Google Scholar
• Purvis JE, Karhohs KW, Mock C, Batchelor E, Loewer A, Lahav G. p53 dynamics control cell fate. Science. 2012;336(6087):1440–1444. doi:10.1126/science.1218351
   PubMed Web of Science ®Google Scholar
• Chi C, Li DJ, Jiang YJ, et al. Vascular smooth muscle cell senescence and age-related diseases: state of the art. Biochim Biophys Acta Mol Basis Dis. 2019;1865(7):1810–1821. doi:10.1016/j.bbadis.2018.08.015
   PubMed Web of Science ®Google Scholar
• Endorf EB, Qing H, Aono J, et al. Telomerase reverse transcriptase deficiency prevents neointima formation through chromatin silencing of E2F1 target genes. Arterioscler Thromb Vasc Biol. 2017;37(2):301–311. doi:10.1161/ATVBAHA.116.308717
   PubMed Web of Science ®Google Scholar
• Wang J, Uryga AK, Reinhold J, et al. Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability. Circulation. 2015;132(20):1909–1919. doi:10.1161/CIRCULATIONAHA.115.016457
   PubMed Web of Science ®Google Scholar